Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

NCT05278975 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

186

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Pleural Effusion
Malignant Pleural Mesothelioma
Mesothelioma
Mesotheliomas Pleural
Mesothelioma; Lung
Pleural Effusion, Malignant

Interventions

DRUG: RSO-021

Sponsor

RS Oncology LLC